European Partnership on One Health Antimicrobial Resistance
(EUP OHAMR)
Capital Type
Public Private Partnership
Investment Size
Large consortium awards
Geographic Scope
Europe, Global
Return Model
Non-Dilutive
Stage Focus
Discovery, Translational, Clinical, One Health
Modality Focus
One Health, Antibiotics, Diagnostics, Surveillance
Overview
Horizon Europe–backed partnership launched in 2025 to coordinate and co-fund AMR research and innovation across human, animal, plant, and environmental health.
Portfolio and Signals
Successor to JPIAMR and a major new European coordination and co-funding node for AMR R&D.
Access and Engagement
Access is primarily through multinational partnership calls, public calls, and consortium-based proposals.
Notable AMR Examples / Programs
EUP OHAMR; successor framework to JPIAMR
Stay Updated
Stay connected so that you don't miss the latest AMR insights and updates.
